Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol

DiscussionThis review will identify relevant literature on the topic to inform prescribers working in oncology and malignant haematology. It will also analyse any evidence of the following outcomes: toxicity, treatment adherence and/or QoL outcomes for patients receiving non-standard doses of oral SACT. Limitations in the evidence base may arise from variability in both the type and quality of studies reviewed.Systematic Review RegistrationPROSPEROCRD42017076195.
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research